By a News Reporter-Staff News Editor at Pharma Business Week — According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for “PROMETRIUM” by Cheryl A. Withycombe, representing AbbVie. This application was made available to the public on July 01, 2014 (see also Trademarks).
The international trademark goods and services class code for this trademark application is 005.
The serial number for this application is 76542564.
As submitted by the applicant, this trademark application relates to the following goods and services: Pharmaceutical preparation used to treat secondary amenorrhea.
The owner/registrar information for this application is: Cheryl A. Withycombe, AbbVie, Dept. V377, AP34-2, 1 N. Waukegan Road, North Chicago IL 60064.
Keywords for this news article include: AbbVie, Trademarks.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC
Trademark Application for “PROMETRIUM” Filed by AbbVie
By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for
- 1 min Read
- 07.9.2014
A weekly five-point roundup of critical events in the energy transition and the implications of climate change for business and finance.
A weekly five-point roundup of critical events in fintech, the future of finance and the next wave of banking industry transformation.
A weekly five-point roundup of critical events in fintech, the future of finance and the next wave of banking industry transformation.
Another major sign of lack of confidence in the Chinese economy comes from looking at capital flows in and out of the country.
